NWRN.SW
Price:
$8.01
Market Cap:
$164.00M
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.[Read more]
Industry
Biotechnology
IPO Date
2006-12-12
Stock Exchange
SIX
Ticker
NWRN.SW
According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 62.01%. This represents a change of 56.69% compared to the average of 39.57% of the last 4 quarters.
The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is -63.92%. The current 62.01% ROE has changed -197.01% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's ROE was at its highest in in the June 2022 quarter at 164.65%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.
Average
-63.92%
Median
-32.56%
Minimum
-479.59%
Maximum
124.68%
Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 293.90%
Maximum Annual ROE = 124.68%
Minimum Annual Increase = -126.00%
Minimum Annual ROE = -479.59%
Year | ROE | Change |
---|---|---|
2023 | 54.25% | -56.49% |
2022 | 124.68% | -126.00% |
2021 | -479.59% | 293.90% |
2020 | -121.76% | 121.72% |
2019 | -54.91% | 100.28% |
2018 | -27.42% | 251.53% |
2017 | -7.80% | -74.54% |
2016 | -30.63% | -50.18% |
2015 | -61.48% | 78.20% |
2014 | -34.50% | 2.51% |
The current ROE of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-100.22%
5-year avg
-95.47%
10-year avg
-63.92%
Newron Pharmaceuticals S.p.A.’s ROE is less than Santhera Pharmaceuticals Holding AG (188.73%), greater than Basilea Pharmaceutica AG (-19.22%), less than Addex Therapeutics Ltd (105.53%), greater than Evolva Holding SA (-320.04%), less than Cosmo Pharmaceuticals N.V. (15.11%),
Company | ROE | Market cap |
---|---|---|
188.73% | $104.96M | |
-19.22% | $527.27M | |
105.53% | $16.18M | |
-320.04% | $6.35M | |
15.11% | $1.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Newron Pharmaceuticals S.p.A.'s ROE?
How is the ROE calculated for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
What is the highest ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
What is the 3-year average ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
What is the 5-year average ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW)?
How does the current ROE for Newron Pharmaceuticals S.p.A. (NWRN.SW) compare to its historical average?